10 results on this page
The US Department of Justice has intervened in support of xAI's challenge to a Minnesota law banning AI nudification tools. A federal judge heard arguments and said a ruling on xAI's request for a preliminary injunction would come soon.
Long-form audiences remain highly sensitive to visible AI flaws, making full-stack AI production risky for films and television. Industry leaders are instead adopting human-led workflows where AI supports visual effects, previsualization, cleanup, quality control, and other production bottlenecks.
OpenAI’s Q2 2026 revenue reportedly rose to $6.7 billion, but quarterly growth slowed to 18% while operating losses expanded to $12.3 billion. Ahead of a potential trillion-dollar IPO, the company faces pressure from consumer ARPU limits, enterprise competition, falling API prices, and massive compute commitments.
Tencent is aggressively expanding WorkBuddy through more than 2,000 agents, enterprise discounts, sales commissions, and standardized marketing scripts. The AI office market is shifting from model differentiation toward deployment services, human-heavy implementation, measurable ROI, and price competition.
Callosum has raised $100 million in early financing to develop software that matches specific AI tasks with suitable models and chips. Backers include the UK’s public AI fund.
MiniMax Design uses an Agent to orchestrate multiple models for professional content production. Its positioning reflects a broader shift in AI video competition from model capabilities alone toward integrated products and measurable commercial value.
Nokia is reportedly planning further layoffs, facility closures, and a major reduction of its mainland China operations, potentially retaining only limited after-sales services. The retreat is part of a global restructuring toward AI and cloud businesses, but it may reduce Nokia’s access to China’s large-scale 5G deployment data needed for AI-RAN and future 6G research.
Moderna and Merck reported that a personalized mRNA therapy, intismeran, combined with Keytruda met key recurrence and distant-metastasis survival endpoints in a prespecified interim analysis. The approach uses AI to select up to 34 tumor-specific neoantigens for an individually manufactured treatment.
Xiaomi stabilized in Q2 2026 while expanding its AI strategy across models, chips, and robotics. Its MiMo-V2.5 model led OpenRouter call charts, the Xuanjie chip passed mass verification, and a humanoid robot began factory operations with a reported 98% success rate.
GitLab 19.3 adds bulk SAST False Positive Detection and Agentic SAST Vulnerability Resolution for existing vulnerability backlogs. Teams can automatically assess findings, dismiss likely false positives, and generate ready-to-merge fixes, including for SARIF-imported third-party scanner results.